欢迎访问《现代生物医学进展》编辑部！

目的：了解临床工作实践中支气管哮喘防治指南（GINA 方案）在基层医院的实施情况及遇到的问题并提出今后解决办法。方法：对门诊及病房住院的患者进行调查研究，采用统一设计的表格、问卷及必要的检查，对结果进行统计和分析。结果：正规治疗与非正规治疗的患者的花费情况具有明显差别，差异具有统计学意义。当地91.2%支气管哮喘曾经误诊为慢性支气管炎。治疗不规范，曾吸入激素治疗的占全部患者的18.1%，曾经和正在口服私人配制的平喘药物（粉剂或胶囊）的占65.8%；病情复发时给予输液、利用抗生素治疗的占73.6%；给予大剂量激素、不规范治疗（包括长期用激素治疗、不逐渐减量）治疗的78.7%；结论：当地哮喘治疗还存在很多问题，形式非常严峻，有待于进一步加大GINA 治疗方案的推广。

英文摘要:

Objective: To find the problems of clinical practice guidelines in the prevention and treatment of bronchial asthma (GINA program), and propose solutions in the future. Methods: Clinical patients and patients hospitalized were researched. A unified design, questionnaires, examination necessary statistics and analysis of asthma were formed. Results: There was a significant difference between the cost of the formal and the informal treatment of patients, and the difference was statistically significant. 91.2% of bronchial asthma had been misdiagnosed as chronic bronchitis. The treatment was not standardized. Inhaled corticosteroid therapy has been accounted for 18.1% of all patients. Patients who have had private oral drug (powder or capsules) accounted for 65.8%; 73.6% of recurrence patients were given antibiotics.The large doses of hormones, non-standard treatment (including long-term use of hormone therapy, no gradual reduction) in the treatment of 78.7% in patients. Conclusion: The local treatment of asthma have many problems still, and the situation is very severe. So programs of promotion of GINA need to be increased in the local health system.

View Full Text View/Add Comment Download reader